NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
48 hedge funds and large institutions have $18.6M invested in NantHealth, Inc in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 24 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 52 → 48 (-4)
10% less capital invested
Capital invested by funds: $20.7M → $18.6M (-$2.15M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
63% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 24
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$634K |
| 2 |
State Street
Boston,
Massachusetts
|
+$121K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$81K |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$55.2K |
| 5 |
VF
Virtu Financial
New York
|
+$49.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$824K |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$672K |
| 3 |
BlackRock
New York
|
-$488K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$257K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$223K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$55K | -1,203 | Closed |
|
52
UBS Group
Zurich,
Switzerland
| – | -$14K | -299 | Closed |
|
53
Parallax Volatility Advisers
San Francisco,
California
| – | -$8K | -182 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | -$5K | -100 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$2K | -44 | Closed |
|
|
IWP
56
Icon Wealth Partners
Houston,
Texas
| – | -$2K | -38 | Closed |
|
NH Hedge Fund Activity: Q1 2018 in Review
48 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q1 2018, worth a combined $18.6M — down 10% from $20.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NH and 5 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 9 added.
The largest buyer was Morgan Stanley, adding an estimated $634K. The largest seller was Alyeska Investment Group, cutting an estimated $824K.
- 48 institutional investors held NantHealth, Inc (NH) as of Q1 2018, down from 52 in Q4 2017.
- Funds reported $18.6M of NantHealth, Inc stock for Q1 2018, down 10% quarter-over-quarter.
- 5 funds opened new NantHealth, Inc positions in Q1 2018 and 9 closed out, a net change of -4 holders.
- The largest NantHealth, Inc buyer in Q1 2018 was Morgan Stanley, an estimated $634K added.
- The largest NantHealth, Inc seller in Q1 2018 was Alyeska Investment Group, an estimated $824K sold.
Based on aggregated 13F filings for Q1 2018.